Patents
Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027)
03/2004
03/17/2004CN1142175C Sulfurization for oestrogen mixture
03/16/2004US6706701 6, 7-oxygenated steroids and uses related thereto
03/10/2004EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives
03/04/2004US20040043974 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease
03/03/2004EP1392713A2 Liver x receptor agonists
03/03/2004EP0998484B1 Method of identifying compounds having reduced systemic effects
03/03/2004CN1479746A Process and intermediates for production of 7-substituted antiestrogens
02/2004
02/24/2004US6696580 Steroids with a cyclohexene moiety are oxidized to the corresponding alpha, beta-unsaturated ketone that is converted to the corresponding vicinal diol using a hydroborating reagent followed by oxidative workup
02/19/2004US20040034029 Composition and method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone
02/19/2004US20040034002 3Alpha-hydroxy-3beta-methoxymethyl-substituted steroids and the use thereof
02/18/2004EP1389623A2 Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin d analogs, and other compounds
02/17/2004US6693090 19-norsteroids substituted in position 11β, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them
02/12/2004WO2004012653A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
02/12/2004US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
02/12/2004DE10233723A1 Preparation of 7 alpha-substituted 11 alpha-hydroxy-steroids, useful as precursors for new androgenic 7 alpha,17 alpha-substituted 11 beta-halo-steroids, by microbiological conversion of 7 alpha-substituted steroids
02/05/2004WO2004011663A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
02/04/2004EP1385868A2 Steroidal derivatives
01/2004
01/29/2004WO2004009613A1 Anti-inflammatory or anti-allergic androstane complexes
01/28/2004EP1383786A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
01/22/2004US20040014734 Anticholesterol agents
01/20/2004CA2123051C Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
01/14/2004EP1379542A2 Treatment of tumours
01/14/2004CN1468253A 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
01/14/2004CN1468252A 6.alpha., 9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
01/07/2004CN1133643C Lactone derivatives of 17-beta-carboxy, carbothio and amide androstane derivatives
01/06/2004US6673783 Fusidic acid derivatives
12/2003
12/31/2003WO2004001369A2 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate
12/31/2003WO2004000795A1 Process for production of vinyl perfluoroalkanesulfonate derivatives
12/31/2003WO2003057855A3 Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
12/31/2003CA2490715A1 Process for producing vinyl perfluoroalkanesulfonate derivative
12/30/2003US6670349 Asthma
12/25/2003US20030236408 Estrogenic compounds as anti-mitotic agents
12/24/2003WO2003105775A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
12/24/2003WO2003066653A3 Process for the production of fluticasone propionate, in particular of polymorphic form 1
12/24/2003CA2491846A1 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
12/18/2003WO2002090375A3 Liver x receptor agonists
12/17/2003CN1131235C 11'beta-halogen-7alpha-substd estratrienes, Preparation of Pharmaceutical preparation containing 11'beta'-halogen-7alpha-substd estratrienes
12/10/2003EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
12/04/2003US20030225051 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
11/2003
11/27/2003WO2002062302A3 Steroidal derivatives
11/20/2003WO2003082896A3 A PROCESS FOR THE PREPARATION OF 6α-FLUORO STEROIDS BY ISOMERISATION OF 6β-FLUOROSTEROIDS
10/2003
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/23/2003WO2003086303A2 Farnesoid x-activated receptor agonists
10/23/2003US20030199529 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
10/23/2003US20030199485 Novel anti-inflammatory androstane derivative
10/23/2003CA2482195A1 Farnesoid x-activated receptor agonists
10/22/2003CN1125077C Sulphamate derivatives of 1,3,5(10)-estratriene derivatives methods of producing them and pharmaceutical compounds containing them
10/21/2003CA2072053C 16-methyl substituted steroids derived from pregna 1,4-diene 3,20-dione, their preparation and application to the preparation of 16-methylene steroids and novel intermediate compounds
10/16/2003WO2003013427A3 A method for preparing fluticasone derivatives
10/09/2003WO2003082896A2 A PROCESS FOR THE PREPARATION OF 6α-FLUORO STEROIDS BY ISOMERISATION OF 6β-FLUOROSTEROIDS
10/09/2003CA2480629A1 A process for the preparation of 6.alpha.-fluoro steroids by isomerisation of 6.beta.-fluorosteroids
10/07/2003US6630587 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
09/2003
09/30/2003CA2114630C Steroid sulphatase inhibitors
09/23/2003US6624156 Methods of making and method of using hybrid cholinergic agents and compositions
09/23/2003US6624155 Hybrid cholinergic agents and compositions
09/12/2003WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
09/11/2003US20030171576 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone.
09/09/2003CA2087298C Bile acid sulfurated derivatives
09/03/2003EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
09/03/2003EP0947504B1 16-ene-vitamin d derivatives
08/2003
08/28/2003US20030162759 Preventing or treating cardiovascular disease including atherosclerosis
08/26/2003US6610866 Reacting unsaturated alkyl ketone with chiral oxazaborolidine compound to form unsaturated alkyl alcohol; intermediates for production of squalamine
08/26/2003US6610844 Removing an 11-alpha-leaving group from an epoxymexrenone derivative
08/26/2003US6610675 Inactive metabolite approach to soft drug design
08/21/2003US20030158432 Sulfating mixture of alkali metal salts of Delta 8,9-dehydroestrone, trioxide complex and adding tris(hydroxymethyl)aminomethane
08/20/2003CN1437610A Oxidation process for preparing the intermediate 6alpha, 9alpha-difluoro-11beta, 17alpha-dihydroxy-16.alpha-methyl-androst-1, 4-dien-3-one-17.Beta-carboxylic acid
08/14/2003WO2003066657A1 A process for preparing ursodeoxycholic acid dusulphate and pharmaceutically acceptable salts thereof
08/14/2003WO2003066656A1 Crystalline complexes of fluticasone 2-furoate
08/14/2003WO2003066655A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
08/14/2003WO2003066654A1 Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid
08/14/2003WO2003066653A2 Process for the production of fluticasone propionate, in particular of polymorphic form 1
08/14/2003WO2003066063A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/14/2003WO2003066036A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions
08/14/2003US20030153542 Novel anti-inflammatory androstane derivative compositions
08/14/2003CA2473896A1 Process for the production of fluticasone propionate, in particular of polymorphic form 1
08/14/2003CA2473753A1 Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid
08/06/2003EP0980381B1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders
07/2003
07/31/2003WO2003035668A3 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha
07/31/2003US20030144257 Administering to a human or animal for inflammation/allergies 6-alpha-9-alpha-difluoro-17 alpha-(2-furanylcarbonyl)oxy)-11 beta-hydroxy-16-alpha-methyl-3-oxo-androsta-1,4-diene-17 beta-carbothioic acid-s-fluoromethyl ester
07/23/2003EP1328538A1 Process and intermediates for the production of 7-substituted antiestrogens
07/22/2003US6596885 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions
07/17/2003WO2003057855A2 Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
07/17/2003WO2003057167A2 Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
07/10/2003US20030130246 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
07/09/2003EP1173430B1 Enantiomers of mercapto lactones and processes for their synthesis
07/08/2003US6589945 Use of sterolsulfates as active substances for producing means to inhibit serin proteases
07/03/2003WO2002094849A3 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process
07/03/2003US20030125387 Antioestrogens, capable of eliciting complete ablation of the trophic effects of oestrogens; cancer therapy
07/01/2003US6586591 Process for preparation of 9,11-epoxy steroids and intermediates useful therein
06/2003
06/17/2003US6579863 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
06/17/2003CA2106966C Ionic reservoir at electrode surface
06/12/2003WO2002009683A9 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
06/12/2003US20030109511 Novel anti-inflammatory androstane derivative compositions
06/04/2003EP0973790B1 Estra-5(10),7-dienes with estrogenic activity
05/2003
05/29/2003US20030100541 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
05/22/2003WO2003042230A1 Non-aromatic heterocyclic esters of furan-2-one-esters of 17. beta.-carboxyl or 17 . beta. -carbothio glucocorticoids
05/22/2003WO2003042229A1 Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
05/22/2003US20030096800 Estrogenic compounds as anti-mitotic agents
05/21/2003EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
05/21/2003EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 21